These data suggest that eIF4E represents a logical therapeutic target to increase tumor cell radiosensitivity and overcome cancer radioresistance that may support potential clinical value of eIF4E-targeting strategies for oral cancer treatment. The gene discussed is EIF4E; the disease is cancer.